1. Home
  2. AMPH vs HQH Comparison

AMPH vs HQH Comparison

Compare AMPH & HQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$21.80

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo abrdn Healthcare Investors Shares of Beneficial Interest

HQH

abrdn Healthcare Investors Shares of Beneficial Interest

HOLD

Current Price

$19.89

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMPH
HQH
Founded
1996
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
AMPH
HQH
Price
$21.80
$19.89
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$29.29
N/A
AVG Volume (30 Days)
393.8K
152.1K
Earning Date
05-06-2026
01-01-0001
Dividend Yield
N/A
11.56%
EPS Growth
N/A
N/A
EPS
2.03
1.09
Revenue
$719,887,000.00
N/A
Revenue This Year
$7.19
N/A
Revenue Next Year
$4.76
N/A
P/E Ratio
$10.67
$18.17
Revenue Growth
N/A
N/A
52 Week Low
$17.03
$15.00
52 Week High
$31.26
$20.46

Technical Indicators

Market Signals
Indicator
AMPH
HQH
Relative Strength Index (RSI) 58.51 66.58
Support Level $20.41 $18.61
Resistance Level $22.90 $20.46
Average True Range (ATR) 0.75 0.40
MACD 0.41 0.23
Stochastic Oscillator 94.35 94.57

Price Performance

Historical Comparison
AMPH
HQH

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About HQH abrdn Healthcare Investors Shares of Beneficial Interest

abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.

Share on Social Networks: